# CD38 mAb Induction + Azathioprine Maintenance for Chronic Active AMR in Kidney Transplant Recipients

> **NCT07718308** · NA · NOT_YET_RECRUITING · sponsor: **wujianyong** · enrollment: 20 (estimated)

## Conditions studied

- Kidney Transplantation
- Antibody-mediated Rejection

## Interventions

- **BIOLOGICAL:** CD38
- **DRUG:** Azathioprine (AZA)
- **OTHER:** Standard Triple Immunosuppression Maintenance

## Key facts

- **NCT ID:** NCT07718308
- **Lead sponsor:** wujianyong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-15
- **Primary completion:** 2028-03-15
- **Final completion:** 2028-03-15
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07718308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07718308, "CD38 mAb Induction + Azathioprine Maintenance for Chronic Active AMR in Kidney Transplant Recipients". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07718308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*